AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glavitop-M Tablet ER

Prescription Icon
Prescription Required

Marketer

Alniche Life Sciences Pvt Ltd

Salt Composition

Metformin (500mg) + Teneligliptin (20mg)

Overview Glavitop-M Tablet ER

Diabexten ER tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent severe diabetic complications like vision impairment and kidney disease, potentially lowering heart attack and stroke risk. Diabexten ER may be used independently or in conjunction with other anti-diabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is tailored to your health status, blood sugar readings, and other medications. Consuming it with meals minimizes stomach upset. Consistent daily intake at the same time maximizes effectiveness; discontinuation requires your physician's approval. Effective blood sugar control reduces the risk of future complications. Adherence to your doctor's diet and exercise plan is crucial for successful diabetes management, as lifestyle choices significantly impact blood sugar control. Common side effects include nausea, vomiting, diarrhea, abdominal discomfort, and headaches. Low blood sugar (hypoglycemia) is a potential side effect, especially when combined with insulin or sulfonylureas; learn how to recognize and manage this. This medication isn't suitable for everyone. Inform your doctor of any pre-existing kidney, liver, heart, or pancreatic conditions, or significant alcohol consumption before starting treatment. Pregnant or breastfeeding individuals should seek medical advice. Interaction with other medications is possible; disclose all medications to ensure safety. Alcohol should be limited due to its potential to lower blood glucose. Your doctor will monitor kidney function and blood sugar levels throughout treatment.

Primary Ingredients of Glavitop-M Tablet ER

No text provided. Please provide the text you would like me to rephrase.

Uses of Glavitop-M Tablet ER

Managing type 2 diabetes

Major Benefits of Glavitop-M Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glavitop-M Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Consume this medicine with a meal.

Common Side effects of Glavitop-M Tablet ER:

  • Nausea
  • Vomiting
  • Headache
  • Hypoglycemia (low blood glucose level)
  • Diarrhea

How to use Glavitop-M Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glavitop-M Extended-Release Tablets. Ingest the tablets whole; do not crush, chew, or break them. Consume this medication with food.

How Glavitop-M Tablet ER works:

Extended-release Glavitop-M tablets contain a dual-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glavitop-M Tablet ER and alcohol is hazardous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glavitop-M tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Patient consultation with their doctor is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Glavitop-M tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Glavitop-M Tablet ER on driving ability is unknown. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

Exercise caution when prescribing Glavitop-M Tablet ER to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician. Glavitop-M Tablet ER is contraindicated in patients exhibiting severe renal insufficiency. Close monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Extended-release Glavitop-M tablets pose a likely risk for individuals with hepatic impairment and should be omitted. Medical advice is recommended.

What if you forget to take Glavitop-M Tablet ER :

Should you forget a Glavitop-M Extended-Release Tablet, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glavitop-M Tablet ER

LabelValue
Developing Good Habits No.
Treatment Category Diabetes Management

FAQs on Glavitop-M Tablet ER

Glavitop-M Tablet ER is safe when used as prescribed. However, even with correct dosage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and hypoglycemia (low blood sugar) may occur. Hypoglycemia is more likely if you're also taking insulin or sulfonylurea. Report any persistent issues to your doctor.
Glavitop-M ER tablets rarely cause hypoglycemia by themselves. However, low blood sugar can result from inadequate calorie intake while using this medication. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness may indicate hypoglycemia, particularly if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic drugs are used concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a quick-acting sugar source, such as glucose tablets, honey, or fruit juice.
Glavitop-M ER tablets may cause nausea and vomiting. If you vomit, sip small amounts of water or other fluids frequently. Contact your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without your doctor's approval.
Glavitop-M ER tablets are contraindicated in patients allergic to any ingredient. This medication is also harmful for those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Glavitop-M Tablet ER can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a rare but serious side effect due to excess lactic acid in the bloodstream. This risk is higher in patients with kidney disease, older adults, and heavy alcohol users, hence its avoidance in these groups. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glavitop-M Tablet ER and seek immediate medical attention.
Prolonged Glavitop-M Tablet ER use can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, altered mental state, and ataxia), so consult your doctor if you experience these symptoms. They may recommend Vitamin B12 level monitoring and supplementation.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Glavitop-M Tablet ER
99
MRP 115
13% off